Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis

ClinicalTrials.gov ID: NCT03772587

Public ClinicalTrials.gov record NCT03772587. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 7:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis

Study identification

NCT ID
NCT03772587
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Momenta Pharmaceuticals, Inc.
Industry
Enrollment
68 participants

Conditions and interventions

Interventions

  • M281 Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 9, 2019
Primary completion
Jun 24, 2020
Completion
Jun 24, 2020
Last update posted
Jun 26, 2023

2019 – 2020

United States locations

U.S. sites
31
U.S. states
18
U.S. cities
29
Facility City State ZIP Site status
Momenta Investigational Site Phoenix Arizona 85013
Momenta Investigational Site Tucson Arizona 85724
Momenta Investigational Site Los Angeles California 90048
Momenta Investigational Site Orange California 92868
Momenta Investigational Site Stanford California 94305
Momenta Investigational Site Aurora Colorado 80045
Momenta Investigational Site New Haven Connecticut 06511
Momenta Investigational Site Boca Raton Florida 33487
Momenta Investigational Site Maitland Florida 32751
Momenta Investigational Site Port Charlotte Florida 33952
Momenta Investigational Site St. Petersburg Florida 33713
Momenta Investigational Site Augusta Georgia 30912
Momenta Investigational Site Meridian Idaho 83642
Momenta Investigational Site Lake Barrington Illinois 60010
Momenta Investigational Site Fairway Kansas 66205
Momenta Investigational Site Boston Massachusetts 02114
Momenta Investigational Site Boston Massachusetts 02115
Momenta Investigational Site Boston Massachusetts 02215
Momenta Investigational Site Detroit Michigan 48202
Momenta Investigational Site East Lansing Michigan 48824
Momenta Investigational Site Columbia Missouri 65212
Momenta Investigational Site New Brunswick New Jersey 08550
Momenta Investigational Site New York New York 10021
Momenta Investigational Site Charlotte North Carolina 28207
Momenta Investigational Site Durham North Carolina 27710
Momenta Investigational Site Raleigh North Carolina 27607
Momenta Investigational Site Cincinnati Ohio 45267
Momenta Investigational Site Columbus Ohio 43210
Momenta Investigational Site Cordova Tennessee 38106
Momenta Investigational Site Austin Texas 78756
Momenta Investigational Site Round Rock Texas 78681

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 30 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03772587, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 26, 2023 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03772587 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →